We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Schwab 1000 Index ETF
SCHK
$5.59B
| $824K | 0.02% |
+27,625
| New | +$761K |
|
|
BASE
1027
DELISTED
Couchbase
BASE
| $820K | 0.02% |
+33,650
| New | +$612K |
|
1028
LifeMD
LFMD
$176M
| $818K | 0.02% |
+60,049
| New | +$567K |
|
1029
NextDecade
NEXT
$1.68B
| $815K | 0.02% |
+91,521
| New | +$710K |
|
1030
GitLab
GTLB
$5.75B
| $815K | 0.02% |
18,072
+4,610
| +34% | +$211K |
|
1031
Paylocity
PCTY
$7.75B
| $815K | 0.02% |
+4,497
| New | +$844K |
|
|
RPC
1032
Ridgepost Capital
RPC
$926M
| $814K | 0.02% |
+79,619
| New | +$853K |
|
1033
Automatic Data Processing
ADP
$109B
| $814K | 0.02% |
+2,638
| New | +$810K |
|
1034
Healthpeak Properties
DOC
$15.5B
| $811K | 0.02% |
46,324
+3,199
| +7% | +$56.8K |
|
|
EH
1035
EHang Holdings
EH
$375M
| $811K | 0.02% |
+46,723
| New | +$793K |
|
1036
Fomento Económico Mexicano
FMX
$41.2B
| $810K | 0.02% |
7,863
+4,819
| +158% | +$497K |
|
1037
Ecolab
ECL
$79.8B
| $807K | 0.02% |
2,994
-12,350
| -80% | -$3.14M |
|
1038
Xperi
XPER
$364M
| $806K | 0.02% |
101,857
+88,237
| +648% | +$665K |
|
1039
Performance Food Group
PFGC
$18.3B
| $805K | 0.02% |
9,203
+6,121
| +199% | +$510K |
|
1040
Trip.com Group
TCOM
$29B
| $803K | 0.02% |
13,695
+8,569
| +167% | +$515K |
|
1041
First Financial Bancorp
FFBC
$3.55B
| $802K | 0.02% |
+33,046
| New | +$784K |
|
1042
Brighthouse Financial
BHF
$3.61B
| $801K | 0.02% |
+14,901
| New | +$838K |
|
1043
Kingstone Companies
KINS
$295M
| $801K | 0.02% |
+51,969
| New | +$862K |
|
1044
Camden Property Trust
CPT
$11.5B
| $799K | 0.02% |
7,093
+4,569
| +181% | +$527K |
|
|
MRX
1045
Marex Group Limited Ordinary Shares
MRX
$4.54B
| $799K | 0.02% |
20,251
+8,113
| +67% | +$338K |
|
1046
Biogen
BIIB
$30.9B
| $793K | 0.02% |
6,318
+4,480
| +244% | +$558K |
|
1047
Bain Capital Specialty
BCSF
$821M
| $793K | 0.02% |
+52,743
| New | +$804K |
|
1048
Immunome
IMNM
$2.62B
| $793K | 0.02% |
+85,227
| New | +$699K |
|
1049
FB Financial Corp
FBK
$2.98B
| $793K | 0.02% |
+17,495
| New | +$760K |
|
1050
Sibanye-Stillwater
SBSW
$6.05B
| $786K | 0.02% |
+108,888
| New | +$595K |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.